New Multisociety Contrast Media Advisory
Monday, August 1, 2022
Read the new timely and widely-accepted best practice recommendations for mitigating the risks of performing interventional pain procedures when iodinated contrast media are in short supply in Interventional Pain Medicine (IPM), the official journal of the International Pain and Spine Intervention Society (IPSIS), published by Elsevier.
These recommendations were developed by IPSIS and the American Academy of Pain Medicine (AAPM) and are also endorsed by
the American Academy of Physical Medicine and Rehabilitation (AAPMR), the American Society of Neuroradiology (ASNR), the American Society of Spine Radiology (ASSR), the North American Neuromodulation Society (NANS), the North American Spine Society
(NASS), and the Society of Interventional Radiology (SIR).
The new, expanded practice advisory further clarifies and provides evidence in support of the recommendations designed to assist physicians who may be considering reuse of ICM vials
for multiple patients, repackaging ICM vials, performing procedures without the use of ICM, or using gadolinium-based contrast media in place of ICM.
It is critical that physicians carefully weigh the risks and benefits of performing procedures without ICM or using an alternative agent in the context of each unique patient’s situation and should involve patients in shared decision making before proceeding.
IPSIS-led collaborative advocacy efforts provide a unified voice on behalf of all interventional pain physicians and the patients they treat. Help sustain this vital advocacy with your donations. The International Pain and Spine Intervention Society (IPSIS) is a tax exempt organization under US section 501(c)(3) of the Internal Revenue Code. As such, contributions are deductible to the extent allowed by law.
|
|